Fibroblast Growth Factor (FGFs) / Fibroblast Growth Factor Receptor (FGFRs) Genetic as a Second-line Therapy for Recurrent / Progressive Gastric Cancer With INCB054828 and Paclitaxel a Study to Evaluate the Safety and Efficacy of Combination Therapy.

Clinical trial NCT05529667 · COMPLETED

Trial details

NCT number: NCT05529667
Sponsor: Yonsei University
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Fibroblast Growth Factors (FGFs)/Fibroblast Growth Factor Receptors (FGFRs) Genetic Aberration Gastric Cancer, INCB054828, Paclitaxel

Start date: 2019-05-27
Primary completion: 2023-08-30
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.